After reviewing the medical records of all patients prescribed oral semaglutide for obesity in both outpatient clinics, we included those who provided informed consent for data collection and analysis in the study
GLP-1 medications may cause serious side effects including risk of thyroid tumors
But theres a valid reason for having this kind of guideline when taking a GLP-1 like Ozempic (the version of semaglutide thats FDA-approved for treatment of type 2 diabetes )
3,4 It can sometimes coexist with other musculoskeletal disorders, such as ossification of the ligamentum flavum (OLF), diffuse idiopathic skeletal hyperostosis (DISH), and ankylosing spondylitis
Retrieved from Barrea, L., Vetrani, C., Verde, L., et al